Israel - engelska - Ministry of Health

rafa laboratories ltd - oxycodone hydrochloride - tablets controlled release - oxycodone hydrochloride 40 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.

Israel - engelska - Ministry of Health

rafa laboratories ltd - oxycodone hydrochloride - tablets controlled release - oxycodone hydrochloride 5 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.

Israel - engelska - Ministry of Health

rafa laboratories ltd - oxycodone hydrochloride - tablets controlled release - oxycodone hydrochloride 5 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.

Irland - engelska - HPRA (Health Products Regulatory Authority)

merz pharmaceuticals gmbh - clostridium botulinum neuro-toxin type a (150 kd), free from complexing proteins - powder for solution for injection - 50 - other muscle relaxants, peripherally acting agents; botulinum toxin

Irland - engelska - HPRA (Health Products Regulatory Authority)

merz pharmaceuticals gmbh - clostridium botulinum neuro-toxin type a (150 kd), free from complexing proteins - powder for solution for injection - 100 - other muscle relaxants, peripherally acting agents; botulinum toxin

Malta - engelska - Medicines Authority

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - clostridium botulinum, toxin type, a - powder for solution for injection - clostridium botulinum toxin type a 100 u - muscle relaxants

Malta - engelska - Medicines Authority

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - clostridium botulinum, toxin type, a - powder for solution for injection - clostridium botulinum toxin type a 50 u - muscle relaxants

Irland - engelska - HPRA (Health Products Regulatory Authority)

laboratoire aguettant - atropine sulfate monohydrate - solution for injection in pre-filled syringe - 0.1 milligram(s)/millilitre - belladonna alkaloids, tertiary amines; atropine - belladonna alkaloids, tertiary amines - atropine sulfate aguettant 0.1 mg/ml, solution for injection in pre-filled syringe is indicated in adults and in paediatric population from birth, but with a body weight superior to 3 kg - as a pre-anaesthetic medication to prevent vagal reactions associated with tracheal intubation and surgical manipulation, - to limit the muscarinic effects of neostigmine, when given postsurgically to counteract non-depolarising muscle relaxants - treatment of hemodynamically compromising bradycardia and/ or atrioventricular block due to excessive vagal tone in emergency situation - cardiopulmonary resuscitation: to treat symptomatic bradycardia and av block - as antidote following overdosage or poisoning with acetylcholinesterase-inhibitors e.g. anticholinesterases, organophosphorus, carbamates and muscarinic mushrooms

Irland - engelska - HPRA (Health Products Regulatory Authority)

merz pharmaceuticals gmbh - clostridium botulinum neuro-toxin type a (150 kd), free from complexing proteins - powder for solution for injection - 200 - other muscle relaxants, peripherally acting agents; botulinum toxin

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - tizanidine hydrochloride - oral tablet - 2mg